论文部分内容阅读
于1983年,在马拉维用WHO推荐的联合化疗方案(WHO/MDT)治疗了499例少菌型麻风,其中4例在治疗期间死亡,24例在随访期间死亡。在随访4年后因非死亡原因失访病人的累积比例为14.4%(68/471)。在随访期间,总复发率每年为6.5‰。男性患者,年龄较轻的病人,诊断时皮损多于10块者,临床分类BB型麻风和(或)组织学分类为未定类者、和(或)完成治疗后麻风菌素反应很弱者复发的危险可能增高。在诊断时,病情愈重,复发率趋向升
In 1983, 499 cases of leprosy of fewer bacteria were treated with WHO-recommended combination chemotherapy (WHO / MDT) in Malawi, 4 of whom died during treatment and 24 died during follow-up. The cumulative proportion of patients lost to follow-up after 4 years of follow-up was 14.4% (68/471). During follow-up, the overall recurrence rate was 6.5 ‰ per year. Male patients, younger patients with more than 10 lesions at diagnosis, clinically classified type BB leprosy and / or histological classification as undeclared, and / or relapse after very low response to lepirin after completion of treatment The danger may be increased. At diagnosis, the more serious the disease, the recurrence rate tends to rise